학술논문

Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults
Document Type
Journal
Source
JOURNAL OF INFECTIOUS DISEASES; FEB 22 2024, 10p.
Subject
Language
English
ISSN
15376613